SynthesisJournal of the American Academy of Dermatology2021

The risk of respiratory tract infections and interstitial lung disease with interleukin 12/23 and interleukin 23 antagonists in patients with autoimmune diseases: A systematic review and meta-analysis.

Shintaro Akiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.